Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients

INTRODUCTION: CD155 is an immune checkpoint protein. Its overexpression is an indicator of poor prognosis in some types of cancer. However, the significance of CD155 expression in patients with triple-negative breast cancer, and the relationship between CD155 and programmed death-ligand 1 (PD-L1) ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Katsuhiro, Ishida, Mitsuaki, Yanai, Hirotsugu, Tsuta, Koji, Sekimoto, Mitsugu, Sugie, Tomoharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195407/
https://www.ncbi.nlm.nih.gov/pubmed/34115802
http://dx.doi.org/10.1371/journal.pone.0253176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195407/
https://www.ncbi.nlm.nih.gov/pubmed/34115802
http://dx.doi.org/10.1371/journal.pone.0253176

Ejemplares similares